JWCTF

$0.20-$0.01 (-4.38%)prev close

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$0.20 – $0.53

0% from low

Exchange

OTC Link

Change$-1.36

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$323M	+32.6%	$-0.80	$-0.80–$-0.80	—	1
2027	$838M	+159.3%	$-0.51	$-0.51–$-0.51	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Beat consensus in 2 of the last 6 reported quarters

Reported	Est. EPS	Actual	Surprise
2025-03-27	$-0.09	$-0.12	-27.3%
2024-08-28	$-0.09	$-0.08	+9.4%
2024-03-20	$-0.11	$-0.13	-16.0%
2023-08-29	$-0.12	$-0.13	-9.4%
2023-03-29	$-0.14	$-0.15	-1.0%
2022-08-30	$-0.17	$-0.16	+7.9%

Symbol	Price	Today	Mkt cap	P/E
JWCTFJW (Cayman) Therapeutics Co. Ltd	$0.20	+0.00%	$84M	—
BRIBFBrii Biosciences Limited	$0.13	+0.00%	$94M	—
BXPHFBotanix Pharmaceuticals Limited	$0.03	+86.67%	$77M	—
GNFTFGenfit S.a.	$15.95	+0.00%	$799M	—
IPHYFInnate Pharma S.A.	$1.65	+0.00%

No one on the platform currently holds JWCTF.

Institutions holding (13F)

No tracked institution reports a position in JWCTF as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

No one on the platform has traded JWCTF yet.